Peripheral neuropathies: new recommendations for neuropathic pain pharmacotherapy

Nat Rev Neurol. 2015 May;11(5):250-2. doi: 10.1038/nrneurol.2015.36. Epub 2015 Mar 17.

Abstract

A recent review and meta-analysis on pharmacotherapy for neuropathic pain provides a precise update on treatment efficacy and adverse effects. The authors offer revised evidence-based recommendations for first-line therapies and subsequent options, but we still a need to improve individual treatment decisions, including nonpharmacological therapies, in affected patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amines / therapeutic use
  • Analgesics, Opioid / therapeutic use
  • Anticonvulsants / therapeutic use
  • Antidepressive Agents / therapeutic use
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Gabapentin
  • Humans
  • Neuralgia / drug therapy*
  • Randomized Controlled Trials as Topic
  • Tramadol
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Amines
  • Analgesics, Opioid
  • Anticonvulsants
  • Antidepressive Agents
  • Cyclohexanecarboxylic Acids
  • Tramadol
  • gamma-Aminobutyric Acid
  • Gabapentin